CytoImmune Therapeutics News and Activities

CytoImmune Therapeutics is a company listed under the stock ticker IMUN (US).

View the org chart displaying its 10 main executives

Most searched biographies at CytoImmune Therapeutics

• Joseph Vidal, Chief Executive Officer
• Richard Santulli, Chairman of the Board
• Omer Butt, Vice President, Regulatory Affairs

Create your alert
to follow the executive moves at CytoImmune Therapeutics.

CytoImmune Therapeutics has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by CytoImmune Therapeutics

• CytoImmune Therapeutics Expands Phase 1 Trial of CYTO-102
• CytoImmune Therapeutics Appoints Dr. José Eduardo Vidal as New CEO to Spearhead Focus on Cell Therapy Development
• CytoImmune Therapeutics Broadens Services: A New Chapter in Development and Manufacturing of Cell Therapies
• CytoImmune Therapeutics Appoints Yulii Bogatyrenko as Chief Business Officer and Expands the Board of Directors with the Appointment of Graeme Bell
• CytoImmune Therapeutics to Present Preclinical Data Highlighting Potential of Novel TRACK-NK Cells to Selectively Target and Kill Hematologic and Solid Tumor Cancer Cells
• CytoImmune Therapeutics Appoints Remus Vezan, M.D., Ph.D., as Chief Medical Officer
• CytoImmune Therapeutics and City of Hope Announce First Patient Dosed in a Phase 1 Trial Evaluating a Novel Off-the-Shelf Engineered Natural Killer Cellular Therapy for the Treatment of Non-Small Cell Lung Cancer
• View more press releases Close

Social media about CytoImmune Therapeutics

• CytoImmune Therapeutics on Wikipedia, Google News & Yahoo Finance
• CytoImmune Therapeutics on LinkedIn, X (Twitter) & YouTube